市場調查報告書
商品編碼
1370645
氣道清除設備市場規模,按設備類型(振盪式呼氣正壓、高頻胸壁振盪)、按應用(慢性阻塞性肺部疾病、支氣管擴張)、最終用途和預測,2023 - 2032 年Airway Clearance Devices Market Size By Device Type (Oscillatory Positive Expiratory Pressure, High Frequency Chest Wall Oscillation ), By Application (Chronic Obstructive Pulmonary Disease, Bronchiectasis), By End-use, & Forecast, 2023 - 2032 |
由於擴大採用攜帶式和方便用戶使用型家庭呼吸護理設備,氣道清除設備市場規模預計從 2023 年到 2032 年將以 5.2% 的年複合成長率擴大。最近,慢性呼吸系統疾病的負擔不斷增加,促使人們越來越偏好方便、舒適的治療選擇。此外,更高的技術進步導致緊湊且易於使用的設備以及鼓勵家庭護理的支持性醫療保健政策將進一步推動市場擴張。
對高頻胸壁振盪和肺內衝擊通氣等新型機制的投資不斷增加,加上產業參與者和研究機構之間不斷加強的合作,也正在促進下一代氣道清除設備的開發。舉個例子,2023 年7 月,醫療科技公司Inogen Inc. 收購了總部位於法國的私人公司Physio-Assist SAS,以實現產品組合多元化,並擴大其在美國和歐洲、中東和非洲地區的產品供應,為慢性病患者提供服務。
氣道清除設備市場分為設備類型、應用、最終用途和區域。
就設備類型而言,由於振盪式呼氣正壓 (OPEP) 領域在治療各種呼吸系統疾病方面的功效,預計其行業價值將在 2023 年至 2032 年期間獲得顯著成長。慢性阻塞性肺病 (COPD) 和囊性纖維化的盛行率不斷上升,推動了對非侵入性有效氣道清除解決方案的需求。此外,對先進 OPEP 設備設計的日益青睞以及呼吸護理醫療支出的增加將有助於該細分市場的成長。
2023年至2032年間,氣道清除裝置市場可能會因慢性阻塞性肺病應用領域而出現顯著成長。人口老齡化的加劇、環境污染的快速發展以及吸煙習慣的負擔正在導致患有慢性阻塞性肺病的患者數量不斷增加。此外,針對慢性阻塞性肺病患者需求的攜帶式和方便用戶使用型設備的迅速進步將推動該細分市場的擴張。
從地區來看,由於呼吸系統疾病盛行率上升、肺部健康意識增強以及老年人口不斷成長,亞太地區氣道清除設備產業預計在 2023 年至 2032 年期間以年複合成長率顯著擴張。技術進步、醫療基礎設施發展以及政府支持呼吸照護的措施正在促進市場發展。此外,區域和國際參與者之間日益加強的合作以及對研發活動的更加重視將促進區域產業的成長。
Airway Clearance Devices Market size is anticipated to expand at 5.2% CAGR from 2023-2032, driven by the increasing adoption of portable and user-friendly devices for home-based respiratory care. Of late, the surging burden of chronic respiratory conditions is fueling the rising preference for convenient and comfortable treatment options. Moreover, the higher technological advancements leading to compact and easy-to-use devices along with supportive healthcare policies for encouraging home-based care will further propel the market expansion.
Rising investments in novel mechanisms, such as high-frequency chest wall oscillation and intrapulmonary percussive ventilation coupled with the increasing collaborations between industry players and research institutions are also fostering the development of next-generation airway clearance devices. To cite an instance, in July 2023, medical technology firm Inogen Inc. acquired Physio-Assist SAS, a privately held company headquartered in France to diversify its portfolio and expand its product offerings across the U.S. and EMEA to serve the chronic disease patients.
The airway clearance devices market is segmented into device type, application, end-use, and region.
With respect to device type, the industry value from the oscillatory positive expiratory pressure (OPEP) segment is estimated to gain significant traction from 2023-2032 owing to its efficacy in treating various respiratory conditions. The rising prevalence of chronic obstructive pulmonary disease (COPD) and cystic fibrosis is driving the demand for non-invasive and effective airway clearance solutions. Moreover, the surging preference for advanced OPEP device designs and increased healthcare expenditure on respiratory care will contribute to the segment growth.
Airway clearance devices market is likely to witness significant growth from the chronic obstructive pulmonary disease application segment between 2023 and 2032. The growing aging population, rapid rate of environmental pollution, and burden of smoking habits are leading to the increasing number of patients suffering from COPD. Additionally, the surging advancements in portable and user-friendly devices tailored to the needs of COPD patients will propel the segment expansion.
Regionally, the APAC airway clearance devices industry is set to expand at notable CAGR from 2023-2032 fueled by the rising prevalence of respiratory disorders, increasing awareness regarding pulmonary health, and the growing elderly population. The technological advancements, healthcare infrastructure developments, and government initiatives for supporting respiratory care are contributing to the market development. Additionally, the increasing collaborations between regional and international players along with the higher emphasis on R&D activities will bolster the regional industry growth.